SCHEMBL19981491

SCHEMBL19981491

COP(C)(=O)N1CCC(C#N)CC1

nearest known ligand 0.31

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.31
KDM4E B2RXH2 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15443900 0.81 ACHE (0.33)
SCHEMBL15871549 0.80
SCHEMBL25775999 0.75
SCHEMBL19981469 0.75
SCHEMBL16209804 0.69 KDM4E (0.33) ALDH1A1KDM4E
SCHEMBL769125 0.67 KDM4E (0.36) ALDH1A1KDM4E
SCHEMBL20019698 0.67 CA12 (0.33)
SCHEMBL19981530 0.67 SMN1; SMN2 (0.38) ALDH1A1KDM4E
SCHEMBL23344666 0.66
SCHEMBL18933177 0.66 GAA (0.41) ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2788487-B1 OLIGONUCLEOTIDE ANALOGUES TARGETING HUMAN LMNA SAREPTA THERAPEUTICS INC (US) 2018-04-04 EP disclosed
EP-2788488-B1 METHODS FOR TREATING PROGEROID LAMINOPATHIES USING OLIGONUCLEOTIDE ANALOGUES TARGETING HUMAN LMNA SAREPTA THERAPEUTICS INC (US) 2018-03-21 EP disclosed